Latest News
AVITA Medical (RCEL) Q3 2025 Earnings Transcript
Via The Motley Fool · November 6, 2025
H&R Block (HRB) Q1 2026 Earnings Call Transcript
Via The Motley Fool · November 6, 2025
IBEX (IBEX) Q1 2026 Earnings Call Transcript
Via The Motley Fool · November 6, 2025
ICU Medical (ICUI) Q3 2025 earnings crush estimates with EPS of $2.03, beating forecasts by 41.6%. The company also raised its full-year outlook, sparking a 10%+ stock surge.
Via Chartmill · November 6, 2025
NuScale Power posts Q3 2025 earnings miss but secures a landmark SMR deployment deal and strengthens its cash position.
Via Chartmill · November 6, 2025
Concentra (CON) beat Q3 2025 earnings and revenue estimates, raised its full-year guidance, and announced a new $100M stock buyback program.
Via Chartmill · November 6, 2025
IBEX (IBEX) Q1 FY2026 earnings crush estimates with a 16.5% revenue surge and a 74% jump in EPS. The BPO leader also raises its full-year financial guidance.
Via Chartmill · November 6, 2025
Codexis stock plunges after Q3 2025 earnings miss estimates, with revenue of $8.6M falling far short of expectations.
Via Chartmill · November 6, 2025
Granite Ridge Resources reports mixed Q3 2025 results, missing EPS and revenue estimates despite strong 27% production growth.
Via Chartmill · November 6, 2025
AVITA Medical's Q3 revenue missed estimates due to reimbursement headwinds, but the company improved cost control and secured key Medicare pricing.
Via Chartmill · November 6, 2025
Via Benzinga · November 6, 2025
Morgan Stanley Direct Lending Fund (MSDL) reported Q3 2025 results, missing earnings and revenue estimates. NAV declined slightly, while the dividend was maintained and core earnings remained stable.
Via Chartmill · November 6, 2025
CytomX Therapeutics Q3 2025 earnings miss analyst estimates for revenue and EPS, triggering a negative market reaction.
Via Chartmill · November 6, 2025
Could Kyndryl be the next big opportunity in IT infrastructure? Join our experts as they dissect its potential and risks in the current market.
Via The Motley Fool · November 6, 2025
Turtle Beach Q3 2025 results show revenue near estimates but an EPS miss. The company reaffirmed its full-year guidance despite the mixed performance.
Via Chartmill · November 6, 2025
Veritone's Q3 2025 earnings beat profit forecasts with a smaller loss, but a slight revenue miss led to a 6% stock drop. The AI firm showed strong software growth and provided optimistic future guidance.
Via Chartmill · November 6, 2025
Synaptics Q1 FY2026 earnings: IoT sales surge 74%, driving revenue growth and an EPS beat. The company's Astra AI platform fuels its edge computing focus.
Via Chartmill · November 6, 2025
AvePoint (AVPT) beat Q3 2025 earnings and revenue estimates, yet its stock fell on mixed full-year sales guidance. Strong SaaS growth and ARR highlight a solid business.
Via Chartmill · November 6, 2025
Sensus SRTS Q3 2025 Earnings Call Transcript
Via The Motley Fool · November 6, 2025
Definitive Healthcare (DH) Q3 earnings beat profit estimates by 23%, sending shares up 7.5%. Revenue slightly missed, but strong cash flow and improved margins impressed investors.
Via Chartmill · November 6, 2025
Cable One's Q3 2025 results show a mixed picture: EPS beat expectations, but revenue missed estimates amid subscriber declines and strategic debt reduction.
Via Chartmill · November 6, 2025
Vasta Platform (VSTA) reported Q3 2025 revenue and earnings that missed analyst estimates, causing a negative market reaction despite some operational growth.
Via Chartmill · November 6, 2025
ICU Medical (ICUI) Q3 2025 Earnings Transcript
Via The Motley Fool · November 6, 2025
Century Aluminum (CENX) missed Q3 2025 revenue and EPS estimates, but the stock rose over 4% in after-hours trading, signaling investor optimism.
Via Chartmill · November 6, 2025
Fox Factory (FOXF) stock plunged after Q3 earnings missed estimates. Adjusted EPS of $0.23 fell far short of forecasts, and weak Q4 guidance fueled a sharp sell-off.
Via Chartmill · November 6, 2025